These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24446292)

  • 1. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
    Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
    Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis.
    Jiang DK; Wang WZ; Ren WH; Yao L; Peng B; Yu L
    J Invest Dermatol; 2011 Jan; 131(1):220-8. PubMed ID: 20861852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
    Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
    Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
    Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
    Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis.
    Xia LY; Zeng XT; Li C; Leng WD; Fan MW
    Asian Pac J Cancer Prev; 2013; 14(10):6127-30. PubMed ID: 24289637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between
    Zhang A; Shi TY; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Hu Y; Wang D; He J; Duan P
    Oncotarget; 2017 Dec; 8(68):112761-112769. PubMed ID: 29348863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
    Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
    Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS; Provazzi PJ; Sobrinho JS; Mann-Prado JC; Reis PM; de Freitas SE; Filho JF; Fukuyama EE; Cordeiro JA; Cury PM; Maniglia JV; Villa LL; Tajara EH; Rahal P
    Cancer Genet Cytogenet; 2004 Apr; 150(1):44-9. PubMed ID: 15041222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
    Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
    Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
    Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
    BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population.
    Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD
    Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
    Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
    PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.
    Ruan XL; Li S; Geng P; Zeng XT; Yu GZ; Meng XY; Gao QP; Ao XB
    Med Sci Monit; 2015 Oct; 21():3048-53. PubMed ID: 26451982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.
    Ye J; Li XF; Wang YD; Yuan Y
    PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.